Telix Pharma
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region 2023-11-08 13:00
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability 2023-10-19 06:01
Telix reports fourth consecutive quarter of positive operating cash flow 2023-10-18 15:42
HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South 2023-09-27 12:00
Telix to Showcase New ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EANM 2023-09-06 14:18
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company 2023-08-23 17:40
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 11:14
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 07:18
First Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed Glioblastoma 2023-08-08 06:24
Telix Reports Continued Double-Digit Revenue Growth and Positive Operating Cash Flow 2023-07-19 16:14
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib 2023-07-19 05:00
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC 2023-06-27 03:51
Telix to Showcase ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline Developments at SNMMI 2023-06-22 19:00
Telix to Expand Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical 2023-06-21 17:32
Telix Urology Innovation Showcase to be held at The Yale Club, New York City 2023-06-21 06:31
First Patient Dosed in Phase II STARBURST Study of TLX250-CDx Exploring Indication Expansion 2023-06-19 08:16
Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer 2023-06-15 19:00
Telix Opens European Radiopharmaceutical Production Facility 2023-06-08 20:00
Telix to Present at Jefferies Healthcare Conference 2023-06-06 08:40
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology 2023-05-25 19:00
1 2 3 4 5 6